Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Merck
McKinsey
McKesson
Harvard Business School

Last Updated: October 6, 2022

Patent: 10,011,584


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 10,011,584
Title:Polymorphic form of [5-fluoro-3-({2-[(4-fluorobenzene) sulfonyl]pyridin-3-yl}methyl)-2-methylindol-1-yl]-acetic acid
Abstract: The invention relates to a polymorphic form of [5-fluoro-3-({2-[(4-fluorobenzene)sulfonyl]pyridin-3-yl}methyl)-2-methyli- ndol-1-yl]-acetic acid which is stable at room temperature and is therefore useful for preparing stable pharmaceutical formulations.
Inventor(s): Grosse-Sender; Katja (Kaiseraugst, CH), Hilfiker; Rolf (Kaiseraugst, CH)
Assignee: ATOPIX THERAPEUTICS LIMITED (London, GB)
Application Number:15/308,288
Patent Claims:see list of patent claims

Details for Patent 10,011,584

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Swedish Orphan Biovitrum Ab (publ) SYNAGIS palivizumab For Injection 103770 06/19/1998 See Plans and Pricing 2034-05-02
Swedish Orphan Biovitrum Ab (publ) SYNAGIS palivizumab Injection 103770 07/23/2004 See Plans and Pricing 2034-05-02
Jubilant Hollisterstier Llc N/A positive skin test control-histamine Injection 103891 03/13/1924 See Plans and Pricing 2034-05-02
Genentech, Inc. XOLAIR omalizumab For Injection 103976 06/20/2003 See Plans and Pricing 2034-05-02
Genentech, Inc. XOLAIR omalizumab Injection 103976 09/28/2018 See Plans and Pricing 2034-05-02
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Johnson and Johnson
Medtronic
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.